Company Filing History:
Years Active: 2025
Title: Michael J Morser: Innovator in Therapeutic Antibodies
Introduction
Michael J Morser is a notable inventor based in San Francisco, CA (US). He has made significant contributions to the field of therapeutic antibodies, particularly in relation to osteopontin. His work focuses on developing innovative solutions for treating osteopontin-associated disorders.
Latest Patents
Morser holds a patent for "Therapeutic antibodies against osteopontin." This patent details therapeutic antibodies that are specific for osteopontin and outlines methods for using them in treatment. The antibodies provided in this patent inhibit thrombin-cleavage of osteopontin or block the activity of thrombin cleavage fragments of osteopontin. Additionally, the patent includes antibody conjugates, pharmaceutical compositions, and kits that incorporate these antibodies and formulations.
Career Highlights
Throughout his career, Morser has worked with prestigious institutions, including Leland Stanford Junior University and the United States Government as represented by the Department of Veterans Affairs. His experience in these organizations has allowed him to contribute to significant advancements in medical research and therapeutic development.
Collaborations
Some of Morser's notable coworkers include Lawrence L K Leung and Timothy Myles. Their collaborative efforts have furthered the research and application of therapeutic antibodies in clinical settings.
Conclusion
Michael J Morser's innovative work in therapeutic antibodies showcases his commitment to advancing medical science. His contributions have the potential to improve treatment options for patients with osteopontin-associated disorders.